🎉 Founding Member Beta — Join our Discord and get 3 months of Pro free. Learn more →

Immunome, Inc.

IMNM Healthcare
$21.87 +$2.57 (13.32%)
Market Cap: $2.47 B
Gurus Holding
3
Popularity Rank
#2957
% of Shares Held
8.00%
Net Activity (Q4 2025)
+$42.96 M

Guru Ownership Trend

Guru Analysis for Immunome, Inc. (IMNM)

Immunome, Inc. (IMNM), a key player in the Healthcare sector, continues to attract institutional attention.

As of Q4 2025, a total of 3 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $197.82 M.

Top institutional holders include Steven Cohen and Jefferies Group.

Institutional sentiment is currently Bullish. This is evidenced by a $42.96 M net inflow during the quarter.

Recent activity highlights Steven Cohen who increased their stake by 45.8%. Conversely, Jefferies Group reduced exposure by 4.8%.

Key Holders

Top 5 by Value

$151.11 M
$42.96 M
$216,948

Top 5 by Conviction

Recent Activity Breakdown (Q4 2025)

+$47.48 M
Total Buy Value
New Buys 0
Additions 1
-$4.52 M
Total Sell Value
Reductions 2
Sold Out 1

Guru Consensus (Q4 2025)

Based on recent activity
Net Sellers
3
Net Buyers
1

FAQs for Immunome, Inc. (IMNM)

Major holders include Steven Cohen ($151.11 M), Jefferies Group ($42.96 M), Joel Greenblatt ($216,948). According to the latest reported data, 3 tracked investment managers collectively hold approximately 9.05 M shares.

According to the latest 13F reporting period, sentiment appears Bullish (Net Buying). There was a net inflow of $42.96 M, with 1 managers increasing positions and 3 managers reducing holdings.

During the most recent reporting period, 2 managers trimmed their positions, while 1 fully exited IMNM. The total reported sell value was $4.52 M.

Yes, 0 managers opened new positions in IMNM, and 1 increased their existing holdings. The total reported buy value was $47.48 M.

Portfolio Manager % Portfolio Activity Shares Value Report Date
0.17% Add 45.8% 7,034,952 $151.11 M Q4 2025
0.22% Reduce -4.8% 2,000,000 $42.96 M Q4 2025
0.00% Reduce -1.0% 10,100 $216,948 Q4 2025
Date
Insider Name
Transaction
Value
Shares
Position / Chg
SEC Form